NCT03431350 2026-04-13QUESTJanssen Research & Development, LLCPhase 2 Active not recruiting136 enrolled 29 charts
NCT03748641 2026-04-13MAGNITUDEJanssen Research & Development, LLCPhase 3 Active not recruiting765 enrolled 16 charts 2 FDA
NCT05968599 2026-02-25A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate CancerPfizerCompleted2,731 enrolled 14 charts